Hearing Disability
14
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Assistant for LIstening and Communication Enhancement
Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV)
Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Effects of an Online Hearing Support for First-time Hearing Aid Users
Product Testing of the FaceView Mask™: Usability Survey
Sight and Hearing Investigation Into Effects on Delirium
Training Listening Skills With the Inclusion of Cognitive Control
Motivational Interviewing in Hearing Aid Users
Leuven Interactive Scheme for hearingTraining Evaluation, and Audiological Rehabilitation
Subjective and Objective Performance With the SONNET2EAS
Validation of a Smartphone-Based Hearing-in-Noise Test (HearMe)
Assessment of e-Audiology for Providing Clinical Services and Support
Recipients With Limited Bimodal Benefit: HA or CROS